CEFEPIME

Generic Name : CEFEPIME

TradeName : ADPIME vial BIOPIME vial CADPIME vial CALPIME inj CEFICAD vial CEFPIME vial CEFUDIX vial CEPIME INJ vial CEPIME vial CHASE vial C-PIME inj C-PIME-T inj EFEPIME inj EFFIMAX vial FORPAR inj INPIME vial INSIPIM inj IPACARE vial IVIPIME vial KAMPI inj KEFAGE vial KEPIME vial KINGCEF INJ vial KPM-1000 inj LEEPIME vial MAGNOVA 500 vial MAGNOVA vial MAPIME vial MAXICEF INJ vial MAXIPIME vial MEGAPIME vial MICROPIME inj MIKAPIME tab NICPIME AM IV/IMvial NITIPIME vial NOVAPIME vial ORPIME vial PATRIAT vial PIMERIV vial POTENTOX inj PRYME vial QUADROCEF vial RADIPIME vial SCUD INJ vial SEFDIN INJ vial SEFPIN inj SEPIN vial S-PIME vial SUPIME vial SWIFT inj TEXTIME vial ULTIPIME vial VEGAPIME vial XEPIME vial XIOPEN inj ZWITER vial

Why it is prescribed (Indications) : This medication is cephalosporin antibiotic, prescribed for certain bacterial infections. It kills sensitive bacteria.

When it is not to be taken (Contraindications) : Hypersensitivity to cefepime or other cephalosporins.

When it is to be taken : IV UTI 0.5-1 g 12 hrly for 7-10 days. Empirical therapy for febrile neutropenia 2 g 8 hrly for 7 days or until resolution of neutropenia.

How it should be taken : The drug will be either injected into a large muscle (such as your buttock or hip) or added to an intravenous fluid that will drip through a needle or catheter placed in your vein for 30 minutes, one or two times a day.

Special Instruction :
*Caution should be exercised in patients with history of penicillin or cephalosporin allergy, gastro intestinal disease, especially colitis; lactation, pregnancy, seizures. *It may decrease prothrombin activity; monitor prothrombin time in patients with poor nutritional state, renal or hepatic impairment and those on prolonged treatment. *Prolonged treatment may result in overgrowth of non-susceptible organisms, resulting in superinfection. *Consider the possibility of Clostridium difficile associated diarrhoea in patients who present with diarrhoea after treatment.

Side Effects :
CENTRAL NERVOUS SYSTEM- Headache.
GI- Nausea, vomiting, diarrhea, inflammation of colon, including pseudomembranous colitis; oral candidiasis.
SKIN- Rash; itching, hives.
MISCELLANEOUS- Hypersensitivity, including, allergic reaction, toxic epidermal blistering, rash, inflammation or veins, pain or inflammation at injection site; fever.

Other Precautions :
In diabetes patients - it may cause the results of some tests for urine glucose to be wrong. Becareful while changing the dose of your diabetes medicine.

Storage Conditions :
Injection: In dry state: Store at 2-25°C and protected from light. After reconstitution: This solution is stable for 24 hour at controlled room temperature (2-25°C) and for 7 days under refrigeration (2-8°C).